Breakthroughs in nanozyme-inspired application diversity

Q Zhang, L Song, K Zhang - Materials Chemistry Frontiers, 2023 - pubs.rsc.org
The rapid advancement of nanomaterials has promoted the booming of nanozymes capable
of mimicking natural enzymes. As ideal alternatives to natural enzymes, nanozymes are …

Nanomaterials responsive to endogenous biomarkers for cardiovascular disease theranostics

C Wei, Z Jiang, C Li, P Li, Q Fu - Advanced Functional Materials, 2023 - Wiley Online Library
Cardiovascular disease (CVD) is the number one cause of death worldwide, which propels
the development of advanced technologies for CVD diagnosis and treatment. Biomarker …

Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases

I Arshad, A Kanwal, I Zafar, A Unar, M Hanane… - Environmental …, 2023 - Elsevier
The increasing burden of cardiovascular disease (CVD) remains responsible for morbidity
and mortality worldwide; their effective diagnostic or treatment methods are of great interest …

Precision-engineered metal and metal-oxide nanoparticles for biomedical imaging and healthcare applications

TT Truong, S Mondal, VHM Doan, S Tak, J Choi… - Advances in colloid and …, 2024 - Elsevier
The growing field of nanotechnology has witnessed numerous advancements over the past
few years, particularly in the development of engineered nanoparticles. Compared with bulk …

Advanced drug delivery micro-and nanosystems for cardiovascular diseases

S Iravani, RS Varma - Molecules, 2022 - mdpi.com
Advanced drug delivery micro-and nanosystems have been widely explored due to their
appealing specificity/selectivity, biodegradability, biocompatibility, and low toxicity. They can …

Therapeutic potentials of allicin in cardiovascular disease: advances and future directions

Y Gao, B Wang, G Qin, S Liang, J Yin, H Jiang, M Liu… - Chinese Medicine, 2024 - Springer
Cardiovascular disease (CVD) remains the predominant cause of mortality and disability
worldwide. Against this backdrop, finding effective drugs for the pharmacological treatment …

PLGA-based nanoplatforms in drug delivery for inhibition and destruction of microbial biofilm

A Shariati, Z Chegini, E Ghaznavi-Rad… - Frontiers in Cellular …, 2022 - frontiersin.org
The biofilm community of microorganisms has been identified as the dominant mode of
microbial growth in nature and a common characteristic of different microorganisms such as …

Recent Advancement in Nanotechnology based Drug Delivery for the Management of Cardiovascular disease.

A Ullah, M Ullah, SI Lim - Current problems in cardiology, 2024 - Elsevier
Cardiovascular diseases (CVDs) constitute a predominant cause of both global mortality
and morbidity. To address the challenges in the early diagnosis and management of CVDs …

Progress in biomaterials for cardiac tissue engineering and regeneration

A Scafa Udriște, AG Niculescu, L Iliuță, T Bajeu… - Polymers, 2023 - mdpi.com
Cardiovascular diseases are one of the leading global causes of morbidity and mortality,
posing considerable health and economic burden on patients and medical systems …

[HTML][HTML] Co-doped ZnO nanowires: Synthesis, photocatalytic performance, and cytotoxic activity against human brain glioblastoma cells

K Hamidian, M Sarani, A Najafidoust… - Results in …, 2023 - Elsevier
In this paper, we introduced a green method for the preparation of pure and 1, 3, 7, and 10%
cobalt doped zinc oxide (Co-doped ZnO) Nanowires through the application of Salvadora …